Kevin Foy - Search Results

Year	Number of Results
2005	1
2007	1
2009	2
2010	1
2011	3
2012	3
2013	3
2014	3
2015	1
2017	1
2018	3
2019	2
2021	1
2022	0

1

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.

Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators, Holmans P, Jones L, Tabrizi SJ. Moss DJH, et al. Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Lancet Neurol. 2017. PMID: 28642124

2

Post-concussion syndrome.

Foy K, Murphy KC. Foy K, et al. Br J Hosp Med (Lond). 2009 Aug;70(8):440-3. doi: 10.12968/hmed.2009.70.8.43536. Br J Hosp Med (Lond). 2009. PMID: 19684532

3

An overview of the unique challenges facing African-American breast cancer survivors.

Husain M, Nolan TS, Foy K, Reinbolt R, Grenade C, Lustberg M. Husain M, et al. Among authors: foy k. Support Care Cancer. 2019 Mar;27(3):729-743. doi: 10.1007/s00520-018-4545-y. Epub 2018 Nov 20. Support Care Cancer. 2019. PMID: 30460398 Review.

4

Correction to: Foy KC, Miller MJ, Moldovan N, Carson III WE, Kaumaya PTP. Combined vaccination with HER-2 peptide followed by therapy with VEGF peptide mimics exerts effective anti-tumor and anti-angiogenic effects in vitro and in vivo. OncoImmunology 2012; 1:1048-1060.

Foy KC, Miller MJ, Moldovan N, Carson WE, Kaumaya PP. Foy KC, et al. Oncoimmunology. 2013 Jan 1;2(1):e23914. doi: 10.4161/onci.23914. Oncoimmunology. 2013. PMID: 23479552 Free PMC article.

5

Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.

Miller MJ, Foy KC, Kaumaya PT. Miller MJ, et al. Among authors: foy kc. Discov Med. 2013 Mar;15(82):166-76. Discov Med. 2013. PMID: 23545045 Free article. Review.

6

The impact of residual symptoms on outcome of major depression.

Kennedy N, Foy K. Kennedy N, et al. Among authors: foy k. Curr Psychiatry Rep. 2005 Dec;7(6):441-6. doi: 10.1007/s11920-005-0065-9. Curr Psychiatry Rep. 2005. PMID: 16318822 Review.

7

Long-term social functioning after depression treated by psychiatrists: a review.

Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P. Kennedy N, et al. Among authors: foy k. Bipolar Disord. 2007 Feb-Mar;9(1-2):25-37. doi: 10.1111/j.1399-5618.2007.00326.x. Bipolar Disord. 2007. PMID: 17391347 Review.

8

Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington's Disease Using the Enroll-HD Global Platform.

Symonds AL, Macerollo A, Foy K, Alusi SH, Davies R. Symonds AL, et al. Among authors: foy k. Int J Environ Res Public Health. 2021 May 12;18(10):5113. doi: 10.3390/ijerph18105113. Int J Environ Res Public Health. 2021. PMID: 34065918 Free PMC article.

9

Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.

Kaumaya PT, Foy KC. Kaumaya PT, et al. Among authors: foy kc. Future Oncol. 2012 Aug;8(8):961-87. doi: 10.2217/fon.12.95. Future Oncol. 2012. PMID: 22894670 Free PMC article. Review.

10

Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.

McNulty P, Pilcher R, Ramesh R, Necuiniate R, Hughes A, Farewell D, Holmans P, Jones L; REGISTRY Investigators of the European Huntington's Disease Network. McNulty P, et al. J Huntingtons Dis. 2018;7(3):209-222. doi: 10.3233/JHD-170263. J Huntingtons Dis. 2018. PMID: 30103338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results